About this policy
CMS evidence review | evidence_type=Technology Assessment | record_type=technology_assessment | document_id=11 | year=2002
Coverage indications
Medicare conducted an analysis of the scientific evidence related to liver transplantation for patients with malignancies. We found sufficient evidence related to hepatocellular carcinoma to allow us to make a favorable decision. However, our search of the literature did not produce a significant volume of literature, or literature of sufficiently sound methodology, to permit our staff to make a determination regarding liver transplantation for other malignant diagnoses, such as metastatic disease, bile duct carcinoma and epithelioid hemangioendothelioma.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.